September #166 : Burn that Belly

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

Thou Shalt Fear AIDS

Lest We Forget




When to START Drugs?

You Said It

Burn that Belly

In Sync with ZInc

No Butts About It

Preconceptions

HIV a Best Seller?

Considering Cannabis




The Importance of Remembering Ryan White

Insult to Injury

World Cup Wrap Up

Back-to-School Books

Angels Redux

Crying Uncle

Fear & Loathing in Illinois




Editor's Letter

Letters

Keeping Track

GMHC Treatment Issues- September 2010



 
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


Scroll down to comment on this story.


email print

September 2010


Burn that Belly

A new drug may flatten your tummy.

Egrifta (tesamorelin injections) seems headed for FDA approval. The drug treats the accumulation of excess deep visceral belly fat (a type of lipohypertrophy)—a side effect of living with HIV and taking some HIV meds.

In late May, an FDA advisory panel unanimously recommended approval. The panel also recommended more study of Egrifta, citing three problems that surfaced in clinical trials: an increase in blood glucose levels and diabetes risk, a rise in the blood of a substance called insulin-like growth factor (IGF-1, known to promote tumor growth), and a lack of evidence that Egrifta reduces cardiovascular disease risk. At press time, FDA approval was expected any day.

For updates, sign up for our newsletter at poz.com.

Search: Egrifta, tesamorelin injections, FDA. visceral belly fat, diabetes, glucose, insulin, tumor


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


         

[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    fokisi
    Long Beach
    California


    mtaj0818
    Washington
    DC


    ernienyc
    Bronx
    New York


    thebake
    Sioux Falls
    South Dakota
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Will decriminalizing injection drug use help end the global HIV epidemic?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.